Review
Identification of T cell epitopes on hepatitis B surface antigen
Affiliations
- PMID: 1720295
Item in Clipboard
Review
Identification of T cell epitopes on hepatitis B surface antigen
Ann Ist Super Sanita.
1991.
Abstract
The antigenic sites for human T lymphocytes on hepatitis B surface antigen (HBsAg) have been studied using synthetic peptides. The results indicate that aminoacid residues 24-28 of HBsAg (located near the amino terminus of the HBsAg molecule) constitute an immunodominant "helper" determinant, whereas residues 17-18 and/or 34-36 represent a major "suppressor" epitope. However, non responsiveness to currently used hepatitis B virus (HBV) vaccines (employing the whole HBsAg molecule) does not depend, in the vast majority of cases, on suppressor T cells. In vivo experiments with synthetic peptide vaccines are needed to verify the possibility of enhancing the production of protective antibodies against the hepatitis B virus.
Similar articles
-
Human T-helper cell responses to a synthetic peptide derived from the hepatitis B surface antigen.Immunology. 1993 Jul;79(3):362-7. Immunology. 1993. PMID: 7691722 Free PMC article.
-
Recognition of hepatitis B surface antigen by human T lymphocytes. Proliferative and cytotoxic responses to a major antigenic determinant defined by synthetic peptides.J Immunol. 1988 Mar 15;140(6):1808-15. J Immunol. 1988. PMID: 2450132
-
Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.Mol Immunol. 2006 Feb;43(5):436-42. doi: 10.1016/j.molimm.2005.03.002. Epub 2005 Apr 2. Mol Immunol. 2006. PMID: 16337486
-
The distinctive specificity of antigen-specific suppressor T cells.Immunol Today. 1991 Apr;12(4):111-8. doi: 10.1016/0167-5699(91)90094-A. Immunol Today. 1991. PMID: 1711854 Review.
-
Plant-based vaccines against human hepatitis B virus.Expert Rev Vaccines. 2010 Aug;9(8):947-55. doi: 10.1586/erv.10.67. Expert Rev Vaccines. 2010. PMID: 20673016 Review.